Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; water for injections; dibasic sodium phosphate - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are intolerant or insufficiently responsive to another intraocular pressure lowering medication. indications as at 4 february 2003: reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; sodium chloride; benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate; benzalkonium chloride; water for injections; monobasic sodium phosphate monohydrate - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; benzalkonium chloride; sodium chloride; water for injections; monobasic sodium phosphate monohydrate - reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; sodium hydroxide; dibasic sodium phosphate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; benzalkonium chloride; sodium chloride; monobasic sodium phosphate monohydrate; water for injections - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; water for injections; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalamol 50/5 should not be used to initiate therapy.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops - excipient ingredients: dibasic sodium phosphate; monobasic sodium phosphate monohydrate; water for injections; sodium chloride; benzalkonium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops - excipient ingredients: water for injections; dibasic sodium phosphate; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops - excipient ingredients: dibasic sodium phosphate; monobasic sodium phosphate monohydrate; water for injections; benzalkonium chloride; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.